D. Salmon, F. Dabis, L. Wittkop, L. Esterle, P. Sogni et al., Scientific Committee of the ANRS CO13 HEPAVIH Study Group

:. B. Anatomo-pathologie and . Terris, Virologie: A. Krivine

, Maladies Infectieuses et Tropicales: C. Katlama, M. A. Valantin, H. Stitou

F. Charlotte, Virologie: S. Fourati

, APHP Pitié-Salpétrière

A. Sainte-marguerite and M. , Virologie: C. Tamalet)

, APHP Tenon

, Virologie: C. Le Pendeven

, Toulouse (Maladies Infectieuses et Tropicales: B. Marchou

:. L. Hépato-gastro-entérologie, K. Alric, S. Barange, and . Metivier,

. Anatomo-pathologie, Virologie: F. Larroquette

, Virologie: C. Partouche)

, Médecine Interne-Unité VIH: O. Bouchaud; Anatomo-pathologie: M. Ziol

J. Hôpital, . Ducuing, :. M. Toulouse-(médecine-interne, A. Uzan, D. Bicart-see et al., Virologie: F. Nicot

A. Bichat and -. , Virologie: G. Alexandre

A. Saint-louis,

P. Bertheau and J. Duclos, Virologie: P. Palmer

;. K. Aphp-saintantoine, P. Lacombe, . ;. Campa, . Girard, :. D. Anatomo-pathologie et al., Maladies Infectieuses et Tropicales

, APHP Bicêtre

, Virologie: C. Pallier; Maladies Infectieuses: D. Vittecoq

, Virologie: A. Mélard

M. Infectieuses, :. D. Tropicales, A. Neau, E. Ochoa, S. Blanchard et al., Virologie: P. Trimoulet, S. Reigadas

P. Morlat, D. Lacoste, F. Bonnet, N. Bernard, M. Bonarek-hessamfar et al., Virologie: P. Trimoulet, S. Reigadas

. Hôpital-du-haut-levêque, :. J. Bordeaux-(médecine-interne, J. F. Pellegrin, E. Viallard, C. Lazzaro et al., Virologie: P. Trimoulet, S. Reigadas

F. Hôpital, :. D. Suresnes-(médecine-interne, C. Zucman, and . Majerholc, Virologie: F. Guitard)

. Aphp-antoine-béclère, :. F. Clamart-(médecine-interne, J. Boué, I. Polo-devoto, V. Kansau et al., Virologie: C. Deback)

C. Mondor,

S. Lévy, J. D. Dominguez, A. S. Lelièvre, G. Lascaux, and . Melica,

, Virologie: A. Rodallec

. Hôpital-de-la-croix-rousse, . Lyon-(maladies, . Infectieuses, :. P. Tropicales, D. Miailhes et al., Virologie: T. T. Le-Thi

. Chu-dijon, :. L. Dijon-(département-d'infectiologie, P. Piroth, M. D. Chavanet, M. Van-huyen et al., Simonet-Lann, D. Croisier-Bertin

, Perpignan (Maladies infectieuses et tropicales: H. Aumaître)

. Chu-robert-debré, Reims (Médecine interne, maladies infectieuses et immunologie clinique: F

D. Bani-sadr, Y. Lambert, C. Nguen, J. L. Rouger, and . Berger,

C. Strasbourg, (. Rey, M. Partrisiani, P. Gautner, and M. L. Batard,

P. Ritleng, V. Honoré, S. Payssan, A. Breau, M. Joulie et al., Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons, vol.11, pp.514-534, 2016.

M. M. Hassan, M. R. Spitz, M. B. Thomas, A. S. El-deeb, K. Y. Glover et al., Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study, Int J Cancer, vol.123, pp.1883-91, 2008.

L. Brunet, E. E. Moodie, K. Rollet, C. Cooper, S. Walmsley et al., Marijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysis, Clin Infect Dis, vol.57, pp.663-70, 2013.

M. P. Carrieri, L. Serfaty, A. Vilotitch, M. Winnock, I. Poizot-martin et al., Cannabis use and reduced risk of insulin resistance in HIV-HCV

, Clin Infect Dis, vol.61, pp.40-48, 2015.

C. Hezode, E. S. Zafrani, F. Roudot-thoraval, C. Costentin, A. Hessami et al., Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C, Gastroenterology, vol.134, pp.432-441, 2008.

A. J. Budney, R. Roffman, R. S. Stephens, and D. Walker, Marijuana dependence and its treatment, Addict Sci Clin Pract, vol.4, pp.4-16, 2007.

M. J. Milloy, B. Marshall, T. Kerr, L. Richardson, R. Hogg et al., High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs, Drug Alcohol Rev, vol.34, pp.135-175, 2015.

S. Cinti, Medical marijuana in HIV-positive patients: what do we know?, J Int Assoc Physicians AIDS Care, vol.8, pp.342-348, 2009.

D. Jong, B. C. Prentiss, D. Mcfarland, W. Machekano, R. Israelski et al., Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea, J Acquir Immune Defic Syndr, vol.38, pp.43-49, 2005.

, European Association for the Study of the liver (EASL), 2016.

S. Barua, R. Greenwald, J. Grebely, G. J. Dore, T. Swan et al., Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States, Ann Intern Med, vol.163, pp.215-238, 2015.

C. E. Costentin, J. B. Trabut, V. Mallet, S. Darbeda, V. Thepot et al., Management of hepatitis C virus infection in heavy drinkers, Alcohol Alcohol, vol.48, pp.337-379, 2013.

H. M. Lekas, K. Siegel, and J. Leider, Challenges facing providers caring for HIV/HCV-coinfected patients, Qual Health Res, vol.22, pp.54-66, 2012.

D. Nunes, R. Saitz, H. Libman, D. M. Cheng, J. Vidaver et al., Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems, Alcohol Clin Exp Res, vol.30, pp.1520-1526, 2006.

D. L. Sylvestre, Treating hepatitis C virus infection in active substance users, Clin Infect Dis, vol.40, pp.321-325, 2005.

H. A. Innes, S. A. Mcdonald, J. F. Dillon, S. Allen, P. C. Hayes et al., Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes, Hepatology, vol.62, pp.355-64, 2015.

M. Russell, M. P. Pauly, C. D. Moore, C. Chia, J. Dorrell et al., The impact of lifetime alcohol use on hepatitis C treatment outcomes in privately insured members of an integrated health care plan, Hepatology, vol.56, pp.1223-1253, 2012.

M. W. Yeung, J. Young, E. Moodie, K. C. Rollet-kurhajec, K. Schwartzman et al., Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort study, HIV Clin Trials, vol.16, pp.100-110, 2015.

M. A. Loko, D. Salmon, P. Carrieri, M. Winnock, M. Mora et al., The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, BMC Infect Dis, vol.10, p.303, 2006.
URL : https://hal.archives-ouvertes.fr/pasteur-01070193

K. Bush, D. R. Kivlahan, M. B. Mcdonell, S. D. Fihn, and K. A. Bradley, The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking, Ambulatory care quality improvement project

, Alcohol Use Disorders Identification Test. Arch Intern Med, vol.158, pp.1789-95, 1998.

K. A. Bradley, A. F. Debenedetti, R. J. Volk, E. C. Williams, D. Frank et al., AUDIT-C as a brief screen for alcohol misuse in primary care, Alcohol Clin Exp Res, vol.31, pp.1208-1225, 2007.

J. B. Carlin, R. Wolfe, C. Coffey, and G. C. Patton, Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort, Stat Med, vol.18, pp.2655-79, 1999.

B. Nalpas, S. Martin, H. Fontaine, P. Fabbro-peray, C. Brechot et al., Impact of medical recommendations on alcohol consumption in HCV positive patients, J Hepatol, vol.35, pp.312-315, 2001.

J. I. Tsui, R. Saitz, D. M. Cheng, D. Nunes, H. Libman et al., Awareness of hepatitis C diagnosis is associated with less alcohol use among persons co-infected with HIV, J Gen Intern Med, vol.22, pp.822-827, 2007.

L. Lan, C. Guillygomarc'h, A. Danielou, H. , L. Dreau et al., A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse, J Hepatol, vol.56, pp.334-374, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00739945

P. Bruggmann, M. Dampz, T. Gerlach, L. Kravecz, and L. Falcato, Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss hepatitis C cohort study, Drug Alcohol Depend, vol.110, pp.167-71, 2010.

D. Dhumeaux, P. Marcellin, and E. Lerebours, Treatment of hepatitis C. The 2002 French consensus, Gut, vol.52, pp.1784-1791, 2003.

V. Amorosa, M. Synnestvedt, R. Gross, H. Friedman, R. R. Macgregor et al., A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia, J Acquir Immune Defic Syndr, vol.39, pp.557-61, 2005.

E. A. Engels, M. V. Brock, J. Chen, C. M. Hooker, M. Gillison et al., Elevated incidence of lung cancer among HIV-infected individuals, J Clin Oncol, vol.24, pp.1383-1391, 2006.

A. R. Lifson, J. Neuhaus, J. R. Arribas, M. Van-den-berg-wolf, A. M. Labriola et al., Smoking-related health risks among persons with HIV in the strategies for Management of Antiretroviral Therapy clinical trial, Am J Public Health, vol.100, pp.1896-903, 2010.

H. Wand, A. Calmy, D. L. Carey, K. Samaras, A. Carr et al., Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection, AIDS, vol.21, pp.2445-53, 2007.

S. G. Deeks, S. R. Lewin, and D. V. Havlir, The end of AIDS: HIV infection as a chronic disease, Lancet, vol.382, pp.1525-1558, 2013.

M. G. Ghany, D. R. Nelson, D. B. Strader, D. L. Thomas, and L. B. Seeff, American Association for Study of Liver Diseases An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases, Hepatology, vol.54, pp.1433-1477, 2011.

D. Boca, F. K. Darkes, and J. , The validity of self-reports of alcohol consumption: state of the science and challenges for research, Addiction, vol.98, pp.1-2, 2003.

S. Darke, Self-report among injecting drug users: a review, Drug Alcohol Depend, vol.51, pp.253-63, 1998.

P. Roux, J. Cohen, C. Lascoux-combe, P. Sogni, M. Winnock et al., Determinants of the underreporting of alcohol consumption by HIV/HCV co-infected patients during face-to-face medical interviews: the role of the physician, Drug Alcohol Depend, vol.116, pp.228-260, 2011.